Intensive treatment program for first-time PTSD patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of an intensive treatment program for adults experiencing post-traumatic stress disorder (PTSD) for the first time. Participants will receive five days of intensive treatment within two weeks, compared to standard weekly sessions. The study will assess the reduction of PTSD symptoms and analyze the societal costs associated with both treatment approaches through questionnaires and interviews conducted over nine months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older
* PTSD diagnosis according to DSM-5 (CAPS-5);
* PTSD diagnosis stemming from 2 or more potentially traumatic events (PTEs)
* seeking first-time treatment for PTSD (or less than 8 sessions);
* employed (working or on sick leave for less than two years)

Exclusion Criteria:

* Current psychotic disorder, severe alcohol or substance use disorder, high suicidal intent (MINI-S for DSM-5) and a concrete suicide plan, or severe aggressive behavior that poses danger for others
* insufficient command of the Dutch language to be able to complete the assessments. This will be determined through clinical judgment at intake.

Where it's running

• Arq Ivp
  Diemen, North Holland, Netherlands Recruiting
• Psychotraumacentrum Haarlem
  Haarlem, North Holland, Netherlands Recruiting
• Psy-Zo!
  Groningen, Provincie Groningen, Netherlands Recruiting
• ARQ Centrum'45
  Oegstgeest, South Holland, Netherlands Recruiting

Study contacts

• Principal investigator: Mirjam Mink-Nijdam, PhD — ARQ National Psychotrauma Center
• Study coordinator: Mirjam Mink-Nijdam, PhD
• Email: m.mink@centrum45.nl
• Phone: +31(0)20 840 7640

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support

  This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.

  Recruiting at 17 sites Phase 2/3 COMPASS Pathways · Tucson, Arizona and 16 other locations · NCT07570654

• Virtual Reality–Assisted Trauma-Focused CBT for PTSD

  A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.

  Recruiting Queen's University, Belfast · Newtownabbey, County Antrim · NCT07914634

• ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury

  This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT07890337

• HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

  This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

• Predicting nightmare awakenings in PTSD using an AI algorithm

  The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.

  Recruiting at 2 sites Direction Centrale du Service de Santé des Armées · Brest and 2 other locations · NCT07851480

• Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced

  This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.

  Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07813962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.